Pharmacokinetics and pharmacodynamic effects of flunixin after intravenous, intramuscular and oral administration to dairy goats

Acta Veterinaria Scandinavica

Volumn 44, Issue 3-4, 2003, Pages 153-159

  Konigsson K ^a   Torneke K ^b   Engeland, I V ^c   Odensvik, K ^a   Kindahl, H ^a,b  

^a Swedish University of Agricultural Sciences   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN F2 ALPHA; FLUNIXIN; FLUNIXIN MEGLUMINE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; GOAT; LIQUID CHROMATOGRAPHY; NONHUMAN; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS INHIBITION; RADIOIMMUNOASSAY; STEADY STATE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLONIXIN; CROSS-OVER STUDIES; FEMALE; GOATS; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; METABOLIC CLEARANCE RATE; PROSTAGLANDINS;

ANIMALIA; CAPRA HIRCUS;

EID: 1842679465     PISSN: 0044605X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Anderson KL, Hunt E, Davis BJ: The influence of anti-inflammatory therapy on bacterial clearance following intramammary Escherichia coli challenge in goats. Veterinary Research Communications 1991, 15, 147-161.
2. Cheng Z, McKeller Q, Nolan A: Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep. Journal of Veterinary Pharmacology and Therapeutics 1998, 21, 315-321.
3. 2α secretion during early pregnancy in mares. American Journal of Veterinary Research, 1989, 52, 276-281.
4. Fredriksson G: Some reproductive and clinical aspects of endotoxins in cows with special emphasis on the role of prostaglandins. Acta Veterinaria Scandinavica 1984, 25, 365-377.
5. 2α in goat. Zent. Bl. Vet. Med. A. 1984, 31, 386-392.
6. Gibaldi M, Perrier D: Non compartmental analysis based on statistical moment theory. In: Pharmacokinetics 2nd ed. Eds Swarbrick, J. pp 409-417. Marcel Dekker Inc, New York 1982.
7. Granström E, Kindahl H: Species differences in circulating prostaglandin metabolites. Relevance for the assay of prostaglandin release. Biochimica et Biophysica Acta 1982, 713, 555-569.
8. Landoni MF, Cunningham FM, Lees P: Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modeling. American Journal of Veterinary Research 1995, 56, 786-794.
9. Navarre CB, Ravis WR, Nagilla R, Deshmukh D, Simpkins A, Duran SH, Pugh DG: Pharmacokinetics of flunixin meglumine in llamas following a single intravenous dose. Journal of Veterinary Pharmacology and Therapeutics 2001, 24, 361-364.
10. Odensvik K, Fredriksson G: The effect of intensive flunixin treatment during the postpartum period in the bovine. Journal of Veterinary Medicine A 1993, 40, 561-568.
11. 2α metabolite concentrations after oral and intravenous administration in heifers. Journal of Veterinary Pharmacology and Therapeutics 1995, 18, 254-259.
12. Odensvik K, Johansson IM: High-performance liquid chromatography method for determination of flunixin in bovine plasma and pharmacokinetics after single and repeated doses of the drug, American Journal of Veterinary Research, 1995, 56, 489-495.
13. Odensvik K, Magnusson U: Effect of oral administration of flunixin meglumine on the inflammatory response to endotoxin in heifers. American Journal of Veterinary Research 1996, 57, 201-204.
14. Oukessou M: Kinetic disposition of flunixin meglumine in the camel (Camelus dromedarius). Journal of Veterinary Medicine A 1994, 25, 71-75.
15. Vane JR, Botting RM: Overview - mechanisms of action of anti-inflammatory drugs. Improved nonsteroid anti-inflammatory drugs. COX-2 enzyme inhibitors. pp. 1-27. Kluwer Academic Publishers and William Harvey Press, London 1996.
16. Wasfi IA, Boni NS, Abdel Hadi AA. Elghazali M, Zorob O, Alkatheeri NA, Barezaiq IM: Pharamcokinetics, metabolism and urinary detection time of flunixin after intravenous administration in camels. Journal of Veterinary Pharmacology and Therapeutics 1998, 21, 203-208.
17. Welsh JCM, Lees P, Stodulski G, Cambridge H, Foster AP: Influence of feeding schedule on the absorption of orally administered flunixin in the horse. Equine Veterinary Journal supplement 1992, 11, 62-65.
18. Welsh EM, Mc Kellar QA, Nolan AM: The pharmacokinetics of flunixin meglumine in the sheep. Journal of Veterinary Pharmacology and Therapeutics 1993, 16, 181-188.
19. Welsh EM, Nolan AM: Effect of flunixin meglumine on the thresholds to mechanical stimulation in healthy and lame sheep. Research in Veterinary Science 1995, 58, 61-66.